J&J Loses Bid To Nix Levaquin Award In 8th Circ.
The Eighth Circuit said Tuesday that Johnson & Johnson's pharmaceutical unit must pay $630,000 to a patient who claimed the company deliberately failed to properly warn consumers of the risks linked...To view the full article, register now.
Already a subscriber? Click here to view full article